Fundraising FoxCentreStone Ventures
Venture capitalWinnipeg · Seed–Series A · 3 people tracked
Find your way into CentreStone Ventures
Sign up to see every warm intro you have to CentreStone Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CentreStone Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
CentreStone Ventures backs early-stage life sciences companies developing therapeutics, medical devices, diagnostics and novel drug delivery methods. It targets companies addressing large markets with unmet clinical needs, built on strong intellectual property and a mix of entrepreneurial and technical talent with the potential to lead their markets. Based in Winnipeg at the geographic centre of North America, the firm sources opportunities from research centres across the continent, with particular focus on Western Canada and the U.S. Midwest. Beyond capital, CentreStone partners with scientific entrepreneurs, offering structure, support and guidance to build a foundation for commercial development.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directoriesHolds a Ph.D. in Protein Chemistry from the University of Manitoba and was the first employee and President of the Winnipeg Rh Institute, overseeing the development of WinRho. He has founded several health industry companies including Novopharm Biotech (now Viventia Biotech), Genesys Pharma, Miraculins, Diamedica and Medicure, and has managed development of numerous pharmaceutical candidates.
A Chartered Accountant responsible for the financial operations and reporting of GVI and its client companies. He previously managed financial reporting at Manitoba Telecom Services and was an Audit Senior at Ernst & Young.
Holds a Bachelor of Commerce (Hons.) from the University of Manitoba and joined Genesys Venture Inc. in 2000. He oversees treasury and contract administration, supports fundraising for client companies, and has held executive roles at Miraculins and Kane Biotech.
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Digital Health ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro path
DiaMedica Therapeutics develops therapies aimed at reducing ischemia in patients with serious vascular diseases, with an initial focus on preeclampsia, fetal growth restriction, and acute ischemic stroke.
BiotechDigital HealthMinneapolis, US
David J. Wambeke(Executive Officer)inLorianne Masuoka(Executive Officer)inRick Pauls(Executive Officer, Director)inScott Kellen(Executive Officer)inTodd Verdoorn(Executive Officer)inJulie Krop(Chief Medical Officer)in
Co-investorsShepherd Ventures
Exits · 1
1 IPOsDiaMedica TherapeuticsNASDAQ: DMAC
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| DiaMedica Therapeutics | 6.0% | $4.00 | Dec 2018 | $2.8M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- What stage does CentreStone Ventures invest at?
- CentreStone Ventures invests at the Seed, Series A stages.
- What is CentreStone Ventures's typical check size?
- CentreStone Ventures typically writes checks of $182.5K – $1.8M.
- What sectors does CentreStone Ventures focus on?
- CentreStone Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is CentreStone Ventures located?
- CentreStone Ventures is headquartered in Winnipeg, CA.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is an early-stage, high-conviction investment firm with a dedicated healthcare and life sciences practice backing founders rebuilding medicine at the intersection of science, data, care delivery, and economics.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.